Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • Compensation Framework Study
    • First Interim Report
    • Second Interim Report
    • The Inquiry Report
  • Publication Day
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • Confidential Psychological Support
    • Interim Payments
    • Support Groups
    • Get in touch
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

A preliminary report on the "SNBTS Evaluation of the Ortho HCV Antibody ELISA Test System" looked at transfusion recipients, and found that 1 in 33 multi-transfused patients screened positive (3%). 92 of 146 people with haemophilia from the West of Scotland whose samples were tested were shown to be repeatedly reactive for anti-HCV (63%).

  • Read more about A preliminary report on the "SNBTS Evaluation of the Ortho HCV Antibody ELISA Test System" looked at transfusion recipients, and found that 1 in 33 multi-transfused patients screened positive (3%). 92 of 146 people with haemophilia from the West of Scotland whose samples were tested were shown to be repeatedly reactive for anti-HCV (63%).

Dr Mitchell reported on the Abbott Symposium and presented US guidelines on the implementation of anti-HCV testing.

  • Read more about Dr Mitchell reported on the Abbott Symposium and presented US guidelines on the implementation of anti-HCV testing.

Dr Contreras and Dr Barbara warned that contacting and counselling affected donors would be "an enormous and costly undertaking", that using an assay test that took three hours would be logistically difficult, and that a confirmatory assay was still required.

  • Read more about Dr Contreras and Dr Barbara warned that contacting and counselling affected donors would be "an enormous and costly undertaking", that using an assay test that took three hours would be logistically difficult, and that a confirmatory assay was still required.

Dr Gunson presented the preliminary report on the UKBTS study of surrogate and Chiron testing which noted: "The Chiron test had been used in first time recipients of Factor 8Y. Preliminary results had shown no positives, while most recipients of earlier concentrates were Chiron positive. Further study of stored haemophiliac sera was advocated."

  • Read more about Dr Gunson presented the preliminary report on the UKBTS study of surrogate and Chiron testing which noted: "The Chiron test had been used in first time recipients of Factor 8Y. Preliminary results had shown no positives, while most recipients of earlier concentrates were Chiron positive. Further study of stored haemophiliac sera was advocated."

The Central Blood Laboratories Authority Sub-Committee meeting minutes record that "Members agreed it was important for proper evaluation of the Ortho and Abbott 1&2 tests to be carried out before RTCs decided which test they would adopt." The anticipated commencement date remained 1 July 1991.

  • Read more about The Central Blood Laboratories Authority Sub-Committee meeting minutes record that "Members agreed it was important for proper evaluation of the Ortho and Abbott 1&2 tests to be carried out before RTCs decided which test they would adopt." The anticipated commencement date remained 1 July 1991.

Dr Gunson included a briefing note in case of press inquiries, which stressed the importance of selecting tests with proven reliability.

  • Read more about Dr Gunson included a briefing note in case of press inquiries, which stressed the importance of selecting tests with proven reliability.

Dr Gunson informed the Department of Health: "the other major competitor company feels disadvantaged, and has also caused problems in Scotland."

  • Read more about Dr Gunson informed the Department of Health: "the other major competitor company feels disadvantaged, and has also caused problems in Scotland."

The minister was informed that it was unlikely that routine screening could be introduced before 1 April 1991. In fact, the date of introduction slipped from April to July to September.

  • Read more about The minister was informed that it was unlikely that routine screening could be introduced before 1 April 1991. In fact, the date of introduction slipped from April to July to September.

Dr Gunson stated that he doubted "whether the Newcastle and Glasgow Centres have the laboratory capability to carry out the additional work now proposed."

  • Read more about Dr Gunson stated that he doubted "whether the Newcastle and Glasgow Centres have the laboratory capability to carry out the additional work now proposed."

Dr Pickles wrote to John Canavan: "Dr Gunson has been in touch with all the RTCs about starting dates for HCV testing. There are all sorts of problems still, eg exact choice of test, supplies of this, confirmatory testing arrangements, training etc etc."

  • Read more about Dr Pickles wrote to John Canavan: "Dr Gunson has been in touch with all the RTCs about starting dates for HCV testing. There are all sorts of problems still, eg exact choice of test, supplies of this, confirmatory testing arrangements, training etc etc."

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 251
  • Page 252
  • Page 253
  • Page 254
  • Current page 255
  • Page 256
  • Page 257
  • Page 258
  • Page 259
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.